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Abstract
In this work, we describe the utility of Light, Oxygen, or Voltage-sensing (LOV) flavoprotein domains from plant
phototropins as a reporter for protein expression and function. Specifically, we used iLOV, an enhanced and more
photostable variant of LOV. A pET-based plasmid for protein expression was constructed, encoding a C terminal iLOV-
octahistidine (His8)-tag and a HRV 3C protease cleavage recognition site. Ten different proteins, with various sub-cellular
locations, were cloned into the plasmid, creating iLOV-His8 tag fusions. To test protein expression and how iLOV could be
used as a reporter, the proteins were expressed in three different cell lines, in four different culture media, at two different
temperatures. To establish whether the presence of the iLOV tag could have an impact on the functionality, one of the
proteins, EspG, was over-expressed and purified. EspG is an ‘‘effector’’ protein normally produced by enterohemorrhagic E.
coli strains and ‘‘injected’’ into host cells via the T3SS. We tested functionality of EspG-iLOV fusion by performing functional
studies of EspG in mammalian host cells. When EspG-iLOV was microinjected into the host cell, the Golgi apparatus was
completely disrupted as had previously been observed for EspG.
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Introduction
The over-expression of recombinant proteins, whilst common-
place, is still an early bottleneck in biochemistry and structural
biology. Although many proteins over-express easily in quantities
suitable for both biochemical and structural studies, screening for
optimal expression conditions is often required to maximise the
output. The ability to quickly determine whether a protein is
expressed under certain conditions without relying on more
traditional methods of protein expression detection such as
western blots of whole cell lysate, or partially purified proteins, is
a great aid in high-throughput (HTP) expression studies. In this
regard, fluorescent markers such as green fluorescent protein
(GFP) and its derivatives have been utilised with great success
[1,2,3,4].
Fluorescent proteins offer great potential as effective and easy to
use genetically encoded markers for protein expression and
purification. The proliferation of publications utilising fluorescent
proteins for this purpose has increased steadily (for review see [5]).
A recent example is the novel infra-red protein, IFP, and its use in
HTP expression screening of plant and fungal proteins in
Escherichia coli [6]. Although the current range of fluorescent
proteins cover almost the entire visible spectrum, GFP remains a
popular choice due to its time to maturation, brightness and
photostability [7]. However, GFP is not suitable for all applications
due to its size (27 kDa) and structure (11 stranded b-barrel) and
the reliance on an aerobic environment for fluorescence.
Furthermore, GFP is not folded correctly when targeted to the
periplasm of E. coli by a Sec-translocon signal peptide [8].
Therefore, there is considerable interest in developing alternative
protein-based fluorophores that can be utilised under more
complex HTP expression requirements, such as conditions of
hypoxia.
One alternative reporter is the Light, Oxygen, or Voltage-
sensing (LOV) flavoprotein domain from plant phototropins,
which fluoresce in a similar part of the spectrum as GFP, upon
blue light excitation [9]. The flavin chromophore of the LOV
domain also provides it with a yellow colour that can be used
conveniently to monitor protein purification [10]. Molecular
evolution strategies have already been employed to improve the
fluorescent properties of the LOV domain and enhance its
viability as fluorescent reporter [11–12]. LOV-based fluorescent
proteins are particularly beneficial, as their fluorescence is not
dependent on the presence of oxygen [13] facilitating their utility
under anaerobic environments. Moreover, no specialised micro-
scope investments are necessary to monitor LOV fluorescence
since its spectral properties overlap with those of GFP [11].
Here we present the use of a iLOV-tag [11] [10] as an
alternative expression reporting fluorophore and describe the
design of a novel construct, encoding a C-terminal iLOV-
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octahistidine (His8)-tag. Its small size (,11 kDa) makes the iLOV-
His8 tag ideal for monitoring protein over-expression and
purification. The construct includes a HRV 3C protease cleavage
recognition site located between the protein of interest and the
iLOV-His8 tag allowing removal of the fluorescent domain.
To test the construct, 10 different proteins, with various sub-
cellular locations, were encoded fused to the iLOV-His8 tag
(Table 1). The proteins were expressed in three different cell lines,
in four different culture media, at two different temperatures. The
functionality of the cleavage site was confirmed, by over-
expressing protein P3 (AdhE-D2-iLOV), followed by purification
and cleaving using a His-tagged HRV 3C protease.
To establish whether the presence of the iLOV-His8 tag could
have an impact on the functionality, protein P6 (EspG-iLOV) was
over-expressed and purified. We tested the EspG-iLOV fusion by
repeating functional studies of EspG in mammalian host cells, as
described by Seleyunin et al. that had shown disruption of the
Golgi apparatus [14–15].
In this study we demonstrate the use of iLOV as a novel tool for
the measurement of protein expression using HTP. We describe
the use of the iLOV-tag as a reporter for protein expression and
purification of proteins, confirm the functionality of our construct,
and detail the work-flow for measuring expression using this
system. Furthermore, we test the functionality using an effector
protein fused to iLOV, and show the effector is active following
microinjection into eukaryotic cells.
Materials and Methods
Cloning and construct
In order to allow complete control over the genetic sequence,
DNA 2.0 (http://www.dna20.com) was used to synthesise the
plasmid pET-iLOV-yhaO, containing the yhaO gene from
Escherichia coli TUV-930, a T7 promoter, a C3 protease site
sequence and the region encoding the iLOV domain [11] [10].
The yhaO gene is flanked by NcoI restriction sites allowing the gene
to be excised and permitting in-frame cloning of other genes of
interest into the linearised pET-iLOV vector. The use of gene
synthesis also allowed codon optimisation of the iLOV gene to
maximise potential expression in E. coli.
Targets were selected to represent as disperse a group of
prokaryotic proteins as possible, represented by proteins normally
located in the cytosol, the inner membrane and the periplasm.
Additionally, proteins were included that are normally secreted
through the T3SS (Table 1). However, all soluble proteins were
cloned without their cognate signal sequence, to enhance cytosolic
retention. Each gene was amplified with KOD hotstart polymerase
(Promega) using the primers outlined in Table S1. The reactions
were purified using a Qiagen PCR purification kit, digested with
either NcoI or PciI (New England Biolabs), and purified again.
Purified PCR products and purified, linearised pET-iLOV vector
were ligated using standard conditions. Ligations were trans-
formed into Top10 chemically competent cells (Invitrogen) and
the resulting plasmids were purified using a Qiagen mini prep kit.
The new constructs were confirmed by PCR and sequencing. The
plasmids generated throughout the study are detailed in Table S1.
High-throughput testing for fluorescent protein
expression
High-throughput expression was modified from previously
published protocols [16]. Briefly, 10 proteins were over-expressed
in 3 E. coli expression bacterial strains; C41(lDE3), BL21(lDE3)
pLysS and Rosetta (lDE3) pLysS. Each bacterial strain was grown
in 4 ml cultures of LB, TB, 2YT or M9 minimal media, in
duplicated 48-well deep-well blocks (DWB). The bacterial strains
and media were chosen as they are commonly used in modern
laboratories [17]. After induction with 1 mM isopropyl-b-D-
thiogalactopyranoside (IPTG), one DWB was moved to 25uC,
whilst the other was maintained at 37uC. 100 ml samples were
taken every hour, and the OD600 and the fluorescence intensity
(emission and excitation wavelengths of 485 and 520 nm,
respectively) was measured using a FLUOstar OPTIMA, BMG
Labtech plate reader. After overnight incubation the cells were
harvested by centrifugation at 3720 g. The cell pellets were
suspended in 300 ml BugBuster (Novagen) and incubated at room
temperature for 30 minutes to lyse. From the lysate, 20 ml samples
were applied onto a nitrocellulose membrane and a dot-blot was
performed, using His-probe HRP conjugate (Pierce) to detect the
presence of a His8-tag.
Data presentation
Heat-maps presenting data from the HTP experiments were
created using Microsoft Excel (2003 or above, that supports a
Visual basics application). The data was transferred from the
fluorescence reader in an Excel spread-sheet format, and the rows
and columns were organised as required. For convenience, the
data was normalised to range from 0 to 1. The area of interest was
Table 1. Summary of the proteins used in this study to create the ten iLOV fusions.
Protein number Protein name Localisation Functionality
P1 AdhE-iLOV Cytosolic Bifunctional Acetylaldehyde dehydrogenase/Alcohol
dehydrogenase
P2 AdhED1-iLOV Cytosolic Acetylaldehyde dehydrogenase domain
P3 AdhED2-iLOV Cytosolic Alcohol dehydrogenase domain
P4 YhaO-iLOV Inner membrane Putative serine/threonine transporter
P5 YjdL-iLOV Inner membrane Peptide transporter
P6 EspG-iLOV Secreted Effector protein
P7 EspZ-iLOV Secreted Effector protein
P8 NleH1-iLOV Secreted Effector protein
P9 FklB-iLOV Periplasmic Peptidyl-prolyl cis-trans isomerase
P10 SurA-iLOV Periplasmic Peptidyl-prolyl cis-trans isomerase
doi:10.1371/journal.pone.0052962.t001
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highlighted, and a ‘‘surface contour’’ representation was selected;
the scale of the z-axis can be adjusted. The heat-map was
completed by running the macro (Appendix S1) in the VBA
module within Excel.
Scale up expression and purification
To further test the construct, and the use of iLOV as a marker
for purification, two proteins, P3 (AdhED2-iLOV) and P6 (EspG-
iLOV), were over-expressed in BL21(l. DE3) pLysS cells, and
grown in 26500 ml LB cultures. Post-induction temperature was
25uC. The proteins were purified following established purification
protocols [18]. The espG gene from EHEC O157:H7 was PCR
cloned in-frame into pEGFP-C2 (Clontech) as previously de-
scribed [15]. For bacterial expression 41 amino acid N-terminal
deletions of EspG were used. The expression and purification of
EspGD42 was performed as described elsewhere [15].
Cleavage and separation of the His-iLOV tag
The iLOV-His8 tag was cleaved by adding Human Rhino Virus
(HRV) 3C protease (1 mg protease per 50 mg P3-iLOV fusion) to
the protein and the mix was dialysed against 20 mM Tris pH 7.6,
50 mM NaC, 5 mM DTT, at 4 uC overnight. The following day
the solution was added to 1 ml Ni-NTA beads, pre-equilibrated in
the dialysis buffer. The beads-protein mix was incubated for
1 hour, and the beads were collected by slow centrifugation at
1,000 g for 5 minutes. The colourless supernatant contained the
cleaved protein of interest. Pre- and post-cleavage samples were
applied onto a 10% Bis-Tris polyacrylamide gel for SDS-PAGE
analysis.
Testing the functionality of EspG when fused to iLOV
Normal Rat Kidney (NRK) cells were grown to ,50%
confluency in DMEM, 10% FBS, 1% Penicillin/Streptomycin
on glass coverslips. Microinjection of EspG-iLOV (0.25 mg ml21)
or EspGD42 (0.25 mg ml21) was carried out as previously
described using Cascade Blue (1 mg ml21) as tracking dye [19].
Cells were cultured for 45 min post-microinjection at 37uC, 5%
CO2 and subsequently fixed with 3.7% formaldehyde and
immunohistochemistry was performed following conventional
protocols.
Results
Design of the pET-iLOV expression vector
The pET-iLOV plasmid is based upon the established and
widely utilized pET expression system, the ‘‘gold standard’’ for in
vivo protein expression in E. coli (Figure 1). The gene of interest is
cloned under the control of strong bacteriophage T7 transcription
and translation signals and induction of expression via IPTG
allows the protein of interest to comprise .50% total cell protein
in a few hours. The promoter contains flanking palindromic lac
operator binding sites that result in a 10-fold increase in lac
repressor affinity in vitro relative to the natural promoter [20] and
the Shine-Dalgarno sequence has been optimized for expression in
E. coli.
Expression of iLOV-tagged proteins
The expression levels of the iLOV-tagged proteins were
monitored hourly and the final readings were taken on the next
day, approximately 16 hours after induction. The OD600 readings
showed that the cells grew in all media conditions, with the best
growth in TB and 2YT (the richest media), and the least growth in
M9 minimal media. Incubation temperature appears to have a
protein and cell- line specific effect, as some conditions gave higher
fluorescence readings at 25uC (e.g. P6 and P7 in C41 or pLysS
cells), whereas proteins P1–P3 give higher fluorescence readings at
37uC. These results suggest that the temperature, cell line and
media are parameters that should all be tested when approaching
a new protein. To highlight successful expression of the iLOV-
tagged proteins, the end-point fluorescence intensities are
presented as a heat-map (Figure 2). The majority of the constructs
produced fluorescing protein in at least one condition (8 of 10). To
verify that fluorescence accurately reflected expression of the full-
length fusion protein, we analysed P3 (AdhED2-iLOV) following
induction by addition of IPTG. Western blotting using an anti-
iLOV antibody revealed a band of 56 kDa corresponding to full-
length P3 (Figure 3). No breakdown products were observed on
the Western blot. Fluorescence of the bacteria expressing P3 was
also monitored and assessed for the corresponding time points that
were taken for Western analysis. This showed clear production of
fluorescence following induction and a good correlation with the
Western blot analysis (Figure 3). Of the two that failed to show any
fluorescence, one is P8 (NleH1-iLOV), an effector protein that is
translocated by pathogenic E. coli via the T3SS, and P4 (YhaO-
Figure 1. The pET-iLOV plasmid with key features highlighted
including the iLOV domain (green) and key restriction sites for
cloning genes of interest.
doi:10.1371/journal.pone.0052962.g001
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iLOV), an inner membrane transporter, with the C-terminus
located in the periplasm.
Confirming the details of the construct – C3 Protease
Cleavage
To confirm that the construct performs as expected, P3
(AdhED2-iLOV) was expressed in a 500 ml culture. The protein
over-expressed well, yielding approximately 3 mg, and eluted from
the initial nickel column as a single green fluorescent fraction
(Figure 4A–B). The correct fraction was further confirmed by UV
illumination indicating the presence of AdhED2-iLOV, P3,
(Figure 4C–D). The iLOV-tag was cleaved off by the addition of
a His-tagged HRV C3 protease, and the mixture was analysed by
SDS-PAGE. The molecular weight of the predominant band,
AdhED2, was seen to drop by approximately 16 kDa. The
Figure 2. Heat-map of iLOV fluorescence for the 10 proteins analysed in this study. Each protein-iLOV fusion was cultured in four different
media (LB, TB, 2YT and M9), three different cell lines (C41, pLysS, Rosetta) and at two different temperatures (25uC and 37uC). Peak fluorescence was
determined during the growth curve. Fluorescence data were normalized from the absolute fluorescence values to a scale of 0 to 1. The area of
interest was highlighted, and a ‘‘surface contour’’ representation was selected.
doi:10.1371/journal.pone.0052962.g002
Figure 3. Western blot using an anti-iLOV antibody shows
expression of the full-length AdhED2-iLOV-fusion protein
(‘‘P3’’, A). Expression of AdhED2-iLOV-fusion protein (‘‘P3’’) over time
corresponds with fluorescence, (B). AdhED2-iLOV was expressed in E.
coli C41 cells and the level of fluorescence monitored. The arrow
indicates addition of 1 mM IPTG to induce expression.
doi:10.1371/journal.pone.0052962.g003
Figure 4. Purification of AdhE-D2-iLOV (P3) is easy to follow
due to the distinctive yellow-green colour of the iLOV tagged
protein, (A). Purified AdhE-D2 lacking the iLOV domain is colorless, (B).
Purified P3 shows fluorescence under ultraviolet light, (C). Purified
AdhE-D2 lacking the iLOV domain viewed under uv light (D). The iLOV
domain can be readily cleaved from purified proteins using C3 protease,
(E). Lane M: Markers, Lane 1: AdhE-D2-iLOV, indicated by arrow, Lane 2:
AdhE-D2, iLOV and 3C protease indicated by arrows. The iLOV-His8 tag
has been cleaved off, and the size of AdhE-D2 has been reduced by
approximately 16 kDa.
doi:10.1371/journal.pone.0052962.g004
LOV Based Reporters
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liberated iLOV-His8-tag and His-tagged HRV C3 Protease are
visualised at the bottom of the SDS-PAGE gel (Figure 4E). A
second Ni-NTA step could be used to remove the iLOV-His8-tag
and C3 Protease to further purify the protein.
Confirming the negligible impact of the iLOV tag on the
protein function
EspG is an ‘‘effector’’ protein normally produced by enter-
ohaemorrhagic E. coli strains and ‘‘injected’’ into host cells via the
Type 3 Secretion System (T3SS). Effectors exert discrete activities
on host cell processes with EspG being previously shown to target
ADP-ribosylation factor (ARF) GTPases and p21-activated kinases
(PAKs) in the host [14]. To determine whether the iLOV-His8 tag
has an impact on the functionality of the protein, P6 (EspG-iLOV)
was over-expressed, purified and microinjected into cultured
mammalian cells. Previous studies used EspG D42 (deletion of 42
N-terminal residues), tagged with eGFP to show that EspG D42
efficiently disrupts the streaming of the eukaryotic Golgi complex,
assessed by the observation of tubulovesicular Golgi remnants
(Figure 5, Panel A–C). Similarly, the microinjection of full-length
EspG-iLOV, resulted in rapid and robust disruption of the Golgi,
with a phenotype nearly identical to that previously shown
(Figure 5, Panel D–F). Injection of cascade blue dye alone did not
alter the Golgi in any significant way (Figure 5, Panel G–I).
Discussion
Here we report the use of the iLOV domain as an improved
marker for protein expression and purification and its utility in the
development of a robust HTP screen for a wide range of proteins
expressed in E. coli. The use of a fluorescent tag, in particular GFP,
as a marker of protein expression and purification is a common
and very useful tool to produce protein for use in biophysical or
biochemical studies [1,2,3,4]. The main benefits of iLOV over
GFP for protein expression and purification is that fluorescence is
independent of the aerobic state, enabling correct folding of the
fluorescent marker even in the absence of cellular oxygen [13],
and the significantly smaller molecular weight, permitting
functional studies to be undertaken using purified proteins with
the iLOV-tag still attached. The utility of purified iLOV-tagged
proteins for the determination of sub-cellular localization using
appropriate microscopy techniques, is currently being investigated.
8 of the 10 fusion proteins fluoresce in our expression trials and
these comprised a wide variety of proteins with different functions,
structures and localisations. The high success rate of our tested
constructs is indicative of the robust nature of the iLOV-tag as an
alternative genetically encoded expression marker. The iLOV-tag,
coupled to the His8-tag for ease of purification, has bright
fluorescence enabling expression to be tracked over time using
standard equipment, in this case a fluorometer. The peak
fluorescence has been shown to correspond to the optimal
expression of the construct being tested, providing a good
framework for the HTP screen to be implemented for further
proteins of interest. The vector used in this study contains a C-
terminal iLOV-tag, however, the vector could easily incorporate
an N-terminal tag if the protein of interest so required.
One of the two non-fluorescing fusions generated was NleH1-
iLOV, an effector protein translocated by pathogenic E. coli via the
T3SS and YhaO-iLOV, an inner membrane protein with a
periplasmic C-terminus. Western analysis suggested that YhaO-
iLOV is over-expressed in some of the conditions (data not shown).
The lack of fluorescence in this construct is likely caused by the
fact that YhaO-iLOV is inserted into the membrane via the Sec-
translocon, which transports unfolded protein either into the
membrane or through to the periplasm. Unfolding iLOV releases
the flavin and upon refolding in the periplasmic space, the flavin is
not accessible to be taken up by the iLOV, effectively preventing
fluorescence. Alternatively, folded iLOV will not allow YhaO-
iLOV to insert correctly into the membrane and may have been
deposited in inclusion bodies in the cytoplasm. In the case of
NleH1-iLOV, it is possible that the protein requires its cognate
chaperone for proper folding or alternatively may only exhibit
correct folding when ‘‘injected’’ into eukaryotic host cells. The
remaining proteins that fluoresced encompassed an inner mem-
brane protein, cytosolic proteins, periplasmic proteins and secreted
effector proteins. It is worth bearing in mind that the periplasmic
and effector proteins lack their leading sequence, and therefore
remained in the cytosol. This is a common strategy in protein
over-expression.
The success rate of our constructs suggests that iLOV will be a
valuable tag for a wide variety of systems. The iLOV-His8 tag is
fused to the gene of interest, separated by the sequence encoding a
3C Protease cleavage site, allowing for efficient removal of the
genetically encoded tags. The fractions containing the iLOV-tag
fused to the protein of interest appear bright yellow and can be
tracked visually throughout the purification, allowing fast identi-
fication of protein containing fractions without the need for
western analysis. The use of a pET based vector enabled all the
reported positive features to be exploited for the HTP expression
and purification system and provided a thoroughly tested
framework to determine the utility and functionality of the new
vector (for review see [21]). The ability to tightly control the
expression of the desired protein is the main feature of the pET
system we wished to exploit. This new vector will therefore be used
to express a wide range of proteins, under a diverse range of
conditions to ensure maximal output via the HTP screen proposed
here.
Our results show that the iLOV-His8 tag can be ablated from
the protein of interest, leaving the target protein cleaved and near
wild type in sequence (an addition of PWGAGGLEVLFQ remains
after the tag has been cleaved), to be separated from the iLOV-
Figure 5. Microinjection of wild-type EspGD42 (A), EspG-iLOV
(B), and buffer control (C), into cultured NRK cells. Visualized is
the Golgi protein GM130, cascade blue injection dye, and merge as
indicated in the vertical columns. Scale bar represents 50 mm.
doi:10.1371/journal.pone.0052962.g005
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His8 tag and the protease by a secondary Ni-NTA column. To
determine any potential impact the iLOV-His8 tag could have on
protein functionality, EspG-iLOV and EspGD42 were over-
expressed and microinjected into NRK cells. Heterologously
expressed EspG D42 fused with either GFP or GST has been
shown to be capable of Golgi disruption. This observed organelle
disruption is caused by the targeting of EspG to the GTP-bound
form of the ARF1 GTPase and the subsequent prevention of the
natural nucleotide cycle [15]. Our results confirm these findings,
and highlights that the addition of the iLOV domain to EspG does
not affect the activity of EspG in vivo. This result indicates that
purified iLOV-tagged fusion proteins from the pET-iLOV vector
described here can be easily purified, delivered to target cells and
can be expected to perform in a manner similar to the wild-type
protein. Whilst the fluorescence of EspG-iLOV was not at a
sufficient level to be detected after microinjection, neither was the
EspG-eGFP variant used in the study. However, as recent papers
suggest [12], the development of iLOV as a new fluorophore is just
beginning and newer, brighter, more photostable variants could
easily be incorporated into our pET-iLOV vector as they are
developed and thoroughly tested.
The iLOV-tag utilised here displays amino acid sequence
homology to the newly reported miniSOG, a light and electron
microscopy fusable marker [22]. Whether iLOV will also produce
singlet oxygen, similar to miniSOG, is yet to be determined.
However, as many of the key active sites overlap with iLOV the
potential for visualisation with both light and electron microscopy
(EM) exists. Therefore the possibility for correlative EM (CLEM)
of proteins linked to the iLOV-tag either expressed in vivo or
purified and microinjected makes the HTP screen an attractive
method of screening expression of proteins of interest for this
purpose. The potential applications for iLOV-tagged purified
proteins in visual experimentation is wide, ranging from dissecting
complex host-pathogen interactions to further understanding
specific eukaryotic cell functions applicable to important disease
states.
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